Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of California, San Francisco
Detailed description pending
Age
18–45
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Subjects must have previously participated in the "SOPHIE" study.
Subjects will be between the ages of 18 and 40 years old
Subjects will have been selected as healthy by medical history questionnaire and screening blood work (CBC, Comprehensive Metabolic panel).
Subjects will be taking no regular medications and will have normal renal function.
You may not be if
Pregnant
Have a new history indicating they are no longer healthy; Individuals with anemia (hemoglobin \< 12 g/dL), an elevation in liver enzymes to higher than double the respective normal value, or elevated creatinine concentrations (males ≥ 1.5 mg/dL, females ≥ 1.4 mg/dL), will be excluded.
Taking a medication that could confound study results
Do not consent to participate in the study.
Clareo Health | Influence of Intestinal Transporter Genetic Variants on the Bioavailability of Gabapentin
